Abstract
Photodynamic therapy (PDT) is regarded as a treatment option for basal cell carcinoma (BCC). The aim of this study is to investigate the efficacy of methylene blue (MB)-based PDT in patients suffering from nodular or ulcerative BCCs. This study is a prospective clinical trial with a 6-months follow-up. The study setting is at the Dermatology Clinic at NILES, Cairo University, Egypt. Seventeen patients complaining of nodular BCC (nBCC) and three patients complaining of ulcerative BCC (uBCC) were taken as samples. Methylene blue, the photosensitizer, was prepared in two different formulas: liposomal-loaded MB (LMB) was prepared and formulated in hydrogel (MB 0.2 %) to be used topically alone for treating BCCs <2 cm in diameter or to be combined with intralesional injection (ILI) of free MB 2 % aqueous solution for treating BCCs ≥2 cm in diameter. A session was performed every 2 weeks until complete response (CR) of the lesion or for a maximum of six sessions. Clinical assessments of clinical improvement, dermatological photography, monthly follow-up visits for 6 months, and skin biopsy after 3 months of follow-up to confirm the response, recurrence, or both in cases in which the clinical evaluation was ambiguous. Seventeen patients of the 20 completed the study, 11 patients achieved CR with very good cosmetic outcome, photosensitizer tolerance, and minimal reported side effects. MB is a cheap promising alternative photosensitizer for PDT of nBCC.
Similar content being viewed by others
References
Miller DL, Weinstock MA (1994) Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30(5 Pt 1):774–778
Franceschi S et al (1996) Site distribution of different types of skin cancer: new aetiological clues. Int J Cancer 67(1):24–28
Owens DM, Watt FM (2003) Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 3:444–451
Epstein EH (2008) Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 8:743–754
Scrivener Y, Grosshans E, Cribier B (2002) Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 147(1):41–47
Kwasniak LA, Garcia-Zuazaga J (2011) Basal cell carcinoma: evidence-based medicine and review of treatment modalities. Int J Dermatol 50(6):645–658
Taub AF (2004) Photodynamic therapy in dermatology: history and horizons. J Drugs Dermatol 3(1 Suppl):S8–S25
Calzavara-Pinton PG, Venturini M, Sala R (2007) Photodynamic therapy: update 2006. Part 1: photochemistry and photobiology. J Eur Acad Dermatol Venereol 21(3):293–302
Wainwright M, Crossley KB (2002) Methylene Blue–a therapeutic dye for all seasons? J Chemother 14(5):431–443
Rhodes LE et al (2007) 5-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs. surgery for nodular basal cell carcinoma. Arch Dermatol 143(9):1131–1136
Rhodes LE et al (2004) Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 140(1):17–23
SamarasingheV, Madan V, and Lear JT (2011) Focus on Basal cell carcinoma. J Skin Cancer 2011: p. 328615
Horn M et al (2003) Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 149(6):1242–1249
Cosgarea R, et al. (2012) Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma. J Eur Acad Dermatol Venereol 28(6):0926–9959
Gupta AK, Ryder JE (2003) Photodynamic therapy and topical aminolevulinic acid: an overview. Am J Clin Dermatol 4(10):699–708
Junqueira HC et al (2002) Modulation of methylene blue photochemical properties based on adsorption at aqueous micelle interfaces. Phys Chem Chem Phys 4(11):2320–2328
Noodt BB (1996) Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br J Cancer 74(1):22–29
Wiegell SR, Wulf HC (2006) Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Br J Dermatol 154(5):969–976
Tardivo JP et al (2005) Methylene blue in photodynamic therapy: from basic mechanisms to clinical applications. Photodiagn Photodyn Ther 2(3):175–191
Morton CA et al (2002) Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 146(4):552–567
Muehlmann LA et al (2011) Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy. Braz J Med Biol Res 44(8):729–737
Gulati M et al (1998) Lipophilic drug derivatives in liposomes. Int J Pharm 165(2):129–168
Gerritsen MJ et al (2009) Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology 218(3):193–202
Rodriguez-Prieto MA et al (2012) Photodynamic therapy with intralesional photosensitizer and laser beam application: an alternative treatment for nodular basal cell carcinoma. J Am Acad Dermatol 67(4):e134–e136
Sotiriou E, Apalla Z, Ioannides D (2010) Complete resolution of a squamous cell carcinoma of the skin using intralesional 5-aminolevulinic acid photodynamic therapy intralesional PDT for SCC. Photodermatol Photoimmunol Photomed 26(5):269–271
Kim JE et al (2012) New proposal for the treatment of viral warts with intralesional injection of 5-aminolevulinic acid photodynamic therapy. J Dermatol Treat 23(3):192–195
Kim SK, Shin J, Kim YC (2012) Nodular basal cell carcinoma successfully treated with intralesional 5-aminolevulinic acid injection-photodynamic therapy. Ann Dermatol 24(4):486–487
Evangelou G et al (2011) Successful treatment of cutaneous leishmaniasis with intralesional aminolevulinic acid photodynamic therapy. Photodermatol Photoimmunol Photomed 27(5):254–256
Lee DJ et al (2012) Photodynamic therapy with 5-aminolevulinic acid intralesional injection for pyogenic granuloma. Arch Dermatol 148(1):126–128
Shaaban D, Abdel-Samad Z, El-Khalawany M (2012) Photodynamic therapy with intralesional 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone in the treatment of acne vulgaris: a comparative study. Dermatol Ther 25(1):86–91
Orth K et al (2000) Methylene blue mediated photodynamic therapy in experimental colorectal tumors in mice. J Photochem Photobiol B 57(2–3):186–192
Orth K et al (1998) Photochemotherapy of experimental colonic tumours with intra-tumorally applied methylene blue. Langenbeck’s Arch Surg 383(3–4):276–281
Berroeta L et al (2007) A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma. Br J Dermatol 157(2):401–403
Szeimies RM et al (1994) A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Derm Venereol 74(2):117–119
Clark C et al (2003) Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 19(3):134–141
Baran TM et al (2010) Factors influencing tumor response to photodynamic therapy sensitized by intratumor administration of methylene blue. Lasers Surg Med 42(8):728–735
Morton C, McKenna K, Rhodes L (2008) Guidelines for topical photodynamic therapy: update. Br J Dermatol 159(6):1245–1266
Braathen LR et al (2007) Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International society for photodynamic therapy in dermatology, 2005. J Am Acad Dermatol 56(1):125–143
Morton CA, et al. (2012) European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol
Morton CA, et al. (2012) European guidelines for topical photodynamic therapy part 2: emerging indications - field cancerization, photorejuvenation and inflammatory/infective dermatoses. J Eur Acad Dermatol Venereol
Grapengiesser S et al (2002) Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 27(6):493–497
Zelickson BD (2005) Mechanisms of action of topical aminolevulinic acid. Photodynamic Therapy. 1st ed. Philadelphia: Elsevier Saunders, p. 1–12.
Kalka K, Merk H, Mukhtar H (2000) Photodynamic therapy in dermatology. J Am Acad Dermatol 42(3):389–413, quiz 414–6
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Samy, N.A., Salah, M.M., Ali, M.F. et al. Effect of methylene blue-mediated photodynamic therapy for treatment of basal cell carcinoma. Lasers Med Sci 30, 109–115 (2015). https://doi.org/10.1007/s10103-014-1609-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-014-1609-1